Age-specific lung cancer incidence trends in Canada from 1992 to 2022

IF 2.4 3区 医学 Q3 ONCOLOGY Cancer Epidemiology Pub Date : 2025-02-20 DOI:10.1016/j.canep.2025.102774
Matthew T. Warkentin , Johnathan A. Murray , Yibing Ruan , Kirk Graff , Alain Tremblay , Darren R. Brenner
{"title":"Age-specific lung cancer incidence trends in Canada from 1992 to 2022","authors":"Matthew T. Warkentin ,&nbsp;Johnathan A. Murray ,&nbsp;Yibing Ruan ,&nbsp;Kirk Graff ,&nbsp;Alain Tremblay ,&nbsp;Darren R. Brenner","doi":"10.1016/j.canep.2025.102774","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Lung cancer incidence has historically been higher in males than females, but these rates have been converging. Here we detail the trends in age-specific lung cancer incidence in Canada from 1992 to 2022.</div></div><div><h3>Methods</h3><div>Lung cancer incidence data from 1992 to 2022 by sex and age were obtained from Statistics Canada. We report lung cancer incidence rates and annual percent changes (APC) based on Joinpoint Regression. Birth cohort effects are presented as incidence rate ratios (IRR) with 95 % confidence intervals (CI).</div></div><div><h3>Results</h3><div>Lung cancer incidence has decreased among males aged 35 or above with the largest decreases occurring among those 65 or above. Females under 55 showed similar decreasing trends. However, females 55 or above show stable or increasing incidence rates until around 2017 when rates began decreasing significantly. Birth cohort analysis showed males born after 1957 have lower risk compared to those born at of before 1957. Females risk peaked in 1943–47 and the risk after 1957 slowly returned to early twentieth century levels.</div></div><div><h3>Conclusion</h3><div>The sex difference in lung cancer incidence continues to narrow. Lung cancer rates among males have declined for decades, while the decline among females is more recent and incidence is higher for females at younger ages for the first time.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"95 ","pages":"Article 102774"},"PeriodicalIF":2.4000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877782125000347","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Lung cancer incidence has historically been higher in males than females, but these rates have been converging. Here we detail the trends in age-specific lung cancer incidence in Canada from 1992 to 2022.

Methods

Lung cancer incidence data from 1992 to 2022 by sex and age were obtained from Statistics Canada. We report lung cancer incidence rates and annual percent changes (APC) based on Joinpoint Regression. Birth cohort effects are presented as incidence rate ratios (IRR) with 95 % confidence intervals (CI).

Results

Lung cancer incidence has decreased among males aged 35 or above with the largest decreases occurring among those 65 or above. Females under 55 showed similar decreasing trends. However, females 55 or above show stable or increasing incidence rates until around 2017 when rates began decreasing significantly. Birth cohort analysis showed males born after 1957 have lower risk compared to those born at of before 1957. Females risk peaked in 1943–47 and the risk after 1957 slowly returned to early twentieth century levels.

Conclusion

The sex difference in lung cancer incidence continues to narrow. Lung cancer rates among males have declined for decades, while the decline among females is more recent and incidence is higher for females at younger ages for the first time.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Epidemiology
Cancer Epidemiology 医学-肿瘤学
CiteScore
4.50
自引率
3.80%
发文量
200
审稿时长
39 days
期刊介绍: Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including: • Descriptive epidemiology • Studies of risk factors for disease initiation, development and prognosis • Screening and early detection • Prevention and control • Methodological issues The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.
期刊最新文献
Age-specific lung cancer incidence trends in Canada from 1992 to 2022 Analysis of time trends of prevalence of high-risk HPV infections, high grade cervical precancer and cervical cancer disease in women from Eastern India over 20 years − Pooled analysis from three studies Patterns of recurrence among adults diagnosed with screen-detected lung cancer Corrigendum to “Biased effects of pre-diagnostic physical activity on breast cancer survival: Systematic review and meta-analysis” [Cancer Epidemiol. 89 (2024) 102544] Addressing the cervical cancer burden in the Rio Grande Valley of Texas through a multi-component program to improve screening and diagnostic follow-up: A retrospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1